Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.
Department of Cardiovascular Surgery, Tokyo Women's Medical University, Tokyo, Japan.
PLoS One. 2018 May 23;13(5):e0198026. doi: 10.1371/journal.pone.0198026. eCollection 2018.
We have developed our original tissue engineering technology "cell sheet engineering" utilizing temperature-responsive culture dishes. The cells are confluently grown on a temperature-responsive culture dish and can be harvested as a cell sheet by lowering temperature without enzymatic digestion. Cell sheets are high-cell-density tissues similar to actual living tissues, maintaining their structure and function. Based on this "cell sheet engineering", we are trying to create functional cardiac tissues from human induced pluripotent stem cells, for regenerative therapy and in vitro drug testing. Toward this purpose, it is necessary to evaluate the contractility of engineered cardiac cell sheets. Therefore, in the present study, we developed a contractile force measurement system and evaluated the contractility of human iPSC-derived cardiac cell sheet-tissues. By attaching the cardiac cell sheets on fibrin gel sheets, we created dynamically beating cardiac cell sheet-tissues. They were mounted to the force measurement system and the contractile force was measured stably and clearly. The absolute values of contractile force were around 1 mN, and the mean force value per cross-sectional area was 3.3 mN/mm2. These values are equivalent to or larger than many previously reported values, indicating the functionality of our engineered cardiac cell sheets. We also confirmed that both the contractile force and beating rate were significantly increased by the administration of adrenaline, which are the physiologically relevant responses for cardiac tissues. In conclusion, the force measurement system developed in the present study is valuable for the evaluation of engineered cardiac cell sheet-tissues, and for in vitro drug testing as well.
我们利用温度响应培养皿开发了我们原创的组织工程技术“细胞片工程”。细胞在温度响应培养皿中紧密生长,通过降低温度而无需酶消化即可收获为细胞片。细胞片是类似于实际活体组织的高细胞密度组织,保持其结构和功能。基于这种“细胞片工程”,我们正试图从人类诱导多能干细胞中创建功能性心脏组织,用于再生治疗和体外药物测试。为此,有必要评估工程化心脏细胞片的收缩力。因此,在本研究中,我们开发了一种收缩力测量系统,并评估了人类 iPSC 来源的心脏细胞片组织的收缩性。通过将心脏细胞片附着在纤维蛋白凝胶片上,我们创建了动态搏动的心脏细胞片组织。它们被安装到力测量系统上,可以稳定且清晰地测量收缩力。收缩力的绝对值约为 1 mN,每单位截面积的平均力值为 3.3 mN/mm2。这些值与许多先前报道的值相当或更大,表明我们工程化的心脏细胞片具有功能性。我们还证实,肾上腺素的给药可显著增加收缩力和搏动率,这是心脏组织的生理相关反应。总之,本研究中开发的力测量系统对于评估工程化心脏细胞片组织以及体外药物测试都非常有价值。